A-C
ABI
ABI MODEL
ABBREVIATION
TPA ABBREVIATION
ACTIVATION
PLASMINOGEN ACTIVATOR INHIBITOR 1 ACTIVATION
ALIQUOT
ARG346
ARG356
ARG356
ARG356
ASP355
ASP355
ASP355-PRO357 SEGMENT
ASP355-PRO357 SEGMENT
B DNA SYNTHESIZER
BSA
BACKGROUND PLASMINOGEN ACTIVATOR INHIBITOR-1
BGLII
BGLII
BGLII
BIO-RAD PROTEIN ASSAY REAGENT
C-TERMINAL
CHARACTERIZATION
WTPAI-1 CHARACTERIZATION
COGNATE PROTEASE SPECIFICITY IMPROVEMENT
COMPLEX FORMATION
PAI-1S COMPLEX FORMATION
CONCLUSION SINGLE SITE MUTATION
CONSTRUCTION
WTPAI-1 CONSTRUCTION
CONTROL EXPERIMENT
D355
DNA
DNA MANIPULATION TECHNIQUE
DNA SEQUENCER
ENHANCED           CHEMILUMINESCENCE
ELISA READER
ECOR1
ECORI
ECORI
FG
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FUNCTIONAL STABILITY
FIBROSARCOMA PAI-1 FUNCTIONAL STABILITY
GDN-HCL
GDN-HCL
GDN-HCL
GDN-HCL
GENERAL DNA TECHNIQUE
PLASMID DNA GENERAL DNA TECHNIQUE
GLU
GLU
GLU192
THROMBIN GLU192
GLU350
GLU351
GLU351
GLU351
GLU351
GLU351
GLU351
GLU351
GLU351
GLU351
GLU351
GLU351
GLU351
GLU351
GLU351 MUTANT
PLASMINOGEN ACTIVATOR INHIBITOR 1 GLU351
PLASMINOGEN ACTIVATOR INHIBITOR 1 GLU351
PLASMINOGEN ACTIVATOR INHIBITOR 1 GLU351
GLU39
GND-HCL
GND-HCL
HORSERADISH PEROXIDASE
INCREASED PLASMA LEVEL
PLASMINOGEN ACTIVATOR INHIBITOR 1 INCREASED PLASMA LEVEL
KINETIC ANALYSIS
KJOLLER
LINEAR INCREASE
ABSORBANCE LINEAR INCREASE
M.W
MUTANT
N-GLYCANASE
N-GLYCANASE
N-P-TOSYL-GLY-PRO-LYS-P-NITROANILIDE
NP-40
NACL
NACL
NACL
NACL
NEUTRALIZATION
NEUTRALIZATION
PAI-1S NEUTRALIZATION
PAI-1S NEUTRALIZATION
NON-COGNATE PROTEASE SUBSTITUTION
GLU351 NON-COGNATE PROTEASE SUBSTITUTION
OLIGONUCLEOTIDE
P1 POSITION DISPLAY
P1 RESIDUE
P16-P10
P357
P357
PLASMINOGEN ACTIVATOR INHIBITOR 1 P357
P5'-P11
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PLASMINOGEN ACTIVATOR INHIBITOR 1
PAI-1 ACTIVITY
SERINE PROTEASE SPECIFICITY PLASMINOGEN ACTIVATOR INHIBITOR 1
INHIBITORY ACTIVITY PLASMINOGEN ACTIVATOR INHIBITOR 1
PAI-1 SAMPLE
PAI-1 SEQUENCE
PAI-1 SHARE
PAI-1 YIELD GDN-HCL ACTIVATABLE INHIBITOR
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
PAI-1S
THROMBIN PAI-1S
PAS
PHOSPHATE BUFFERED SALINE
PHOSPHATE BUFFERED SALINE
PCR
PLASMID DNA
PLASMIN
PROFESSOR SHMUEL SHALTIEL
PROMEGA
PROTEIN CONCENTRATION
QIAGEN MINIPREP KIT
R356
RCL
RCL
RCL
RCL
RCL
RCL
RCL
PLASMINOGEN ACTIVATOR INHIBITOR 1 RCL
PLASMINOGEN ACTIVATOR INHIBITOR 1 RCL
RESIDUAL UPA ACTIVITY
S-2288
S-2444
SD
SD
SD
SD
SDS-PAGE
SDS-PAGE
SDS-PAGE
SDS-PAGE
SDS-PAGE
SDS-PAGE
SDS-STABLE COMPLEX
SF-900 SERUM-FREE MEDIUM
SER331
SIMILAR RESULT
SINGLE SITE MUTATION
THROMBIN
THROMBIN
THROMBIN
THROMBIN WTPAI-1
TWEEN-20
TWEEN-20
U/ML
U/UG
U/UG
U/UG
U/UG
U/UG
U/UG
U/UG
U/ΜG
U/ΜG
U/ΜG
U/ΜG
U/ΜG
U/ΜG
U/ΜG
VN
X-RAY STRUCTURE
A-I
ABILITY
ABILITY
ABILITY
ABSENCE
ABSENCE
ABSENCE
ABSENCE
ABSENCE
ABSENCE
ABSENCE
THROMBIN ABSENCE
ABSORBANCE
ABSORBANCE
ACTIVATION
ACTIVATION
ACTIVITY ASSAY BUFFER
ADDING S-2238
ADDITION
ADDITION
ADDITION
HIRUDIN ADDITION
ALANINE
ALIQUOT
ALIQUOT
AMIDOLYTIC ACTIVITY
AMIDOLYTIC ACTIVITY
THROMBIN AMIDOLYTIC ACTIVITY
THROMBIN AMIDOLYTIC ACTIVITY
AMINO-TERMINAL SITE
PLASMIN AMINO-TERMINAL SITE
AMOUNT COMPLEX
ANTI-PAI-1 MONOCLONAL ANTIBODY
ANTI-HUMAN PAI-1
MONOCLONAL ANTIBODY ANTI-HUMAN PAI-1
ANTI-PLASMIN
ASPARAGINE
ASPARTIC ACID
ASPARTIC ACID
ASPARTIC ACID RESIDUE
ASSAY
PLASMINOGEN ACTIVATOR INHIBITOR 1 ASSAY
INHIBITORY ACTIVITY PLASMINOGEN ACTIVATOR INHIBITOR 1 ASSAY
BACULOVIRUS EXPRESSION SYSTEM
BACULOVIRUS EXPRESSION SYSTEM
BACULOVIRUS
BASEPAIR
BETTER THROMBIN INHIBITOR
BOVINE SERUM ALBUMIN
BP
BUFFER
BUFFER
BUFFER
CALLED ACTIVATION
CARBOXYL-TERMINAL
CARDIOVASCULAR DISEASE
CATALYTIC CENTER
TPA CATALYTIC CENTER
CHARGED ANALOG ASPARAGINE
CHARGED ASPARTIC ACID
CHARGED ASPARTIC ACID RESIDUE
CHARGED GLUTAMIC ACID
CHARGED SIDE CHAIN
CHROMATOGRAPHED
CHROMOGENIC ASSAY
CHROMOGENIC ASSAY
CLOSE ANALOG
ASPARTIC ACID CLOSE ANALOG
COMPLEX FORMATION
COMPLEX FORMATION
PAI-1S COMPLEX FORMATION
CONCENTRATION RANGE
CONCOMINANT FORMATION
CONFORMATION
RCL CONFORMATION
CONFORMATIONAL STABILITY
CONFORMATIONAL TRANSITION
CONFORMATIONAL TRANSITION
PLASMINOGEN ACTIVATOR INHIBITOR 1 CONFORMATIONAL TRANSITION
PLASMINOGEN ACTIVATOR INHIBITOR 1 CONFORMATIONAL TRANSITION
CONJUGATED RABBIT ANTI-MOUSE ANTIBODY
CORRESPONDING POSITION
DEGLYCOSYLATION
PLASMINOGEN ACTIVATOR INHIBITOR 1 DEGLYCOSYLATION
DENATURE
DENATURING
DESIRED MUTATION
DETERMINANT
OPTIMAL INTERACTION DETERMINANT
DETERMINING SERPIN INHIBITORY ACTIVITY
DI-DEOXY CHAIN TERMINATION REACTION METHOD
DIALYZED
DILUTED WTPAI-1
DISTAL HINGE
DISTAL HINGE
DISTAL HINGE
DISTAL HINGE
DISTAL HINGE
PLASMINOGEN ACTIVATOR INHIBITOR 1 DISTAL HINGE
PLASMINOGEN ACTIVATOR INHIBITOR 1 DISTAL HINGE
ELUTENT
ENHANCED CHEMILUMINESCENCE
ENHANCED CHEMILUMINESCENCE
ENZYMATIC ASSAY
ENZYMATIC STABILITY ASSAY
ENZYME ASSAY
ESSENTIAL DETERMINANT
ESSENTIAL FUNCTION
PLASMINOGEN ACTIVATOR INHIBITOR 1 ESSENTIAL FUNCTION
EXTENSIVE VARIABLE REGION
FIBRINOLYTIC SYSTEM
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA PAI-1
FIBROSARCOMA CELL
FIBROSARCOMA PREPARATION
PLASMINOGEN ACTIVATOR INHIBITOR 1 FIBROSARCOMA PREPARATION
FINAL CONCENTRATION
FINAL CONCENTRATION
FINAL CONCENTRATION
FINAL CONCENTRATION
FLOW RATE
FORM SD
FORM SD
FORM SDS-STABLE COMPLEX
FORM SDS-STABLE COMPLEX
FUNCTIONAL HALF LIFE
FUNCTIONAL HALF LIFE
MUTANT FUNCTIONAL HALF LIFE
FUNCTIONAL STABILITY
FUNCTIONAL STABILITY
FUNCTIONAL STABILITY
FUNCTIONAL STABILITY
FUNCTIONAL STABILITY
FUNCTIONAL STABILITY
FUNCTIONAL STABILITY
FUNCTIONAL STABILITY
PLASMINOGEN ACTIVATOR INHIBITOR 1 FUNCTIONAL STABILITY
WTPAI-1 FUNCTIONAL STABILITY
WTPAI-1 FUNCTIONAL STABILITY
GEL
GLYCOSYLATION
GRADIENT
GUANIDINE-HYDROCHLORIDE
GUANIDINE-HYDROCHLORIDE
HARVESTING TIME
WTPAI-1 HARVESTING TIME
HELICE
HEPARIN-SEPHAROSE
HEPARIN-SEPHAROSE
HEPARIN-SEPHAROSE COLUMN
HIGH-TITER VIRUS STOCK
HIRUDIN
HIRUDIN
HIRUDIN-INACTIVATED
HISTIDINE
HOMOLOGY
HORSERADISH PEROXIDASE
HORSERADISH PEROXIDASE
HR
HR
HUMAN FIBROSARCOMA CELL
IMMUNOBLOT
IMMUNOBLOTTING
IMMUNOBLOTTING
IMPROVED INHIBITION
IMPROVED REACTIVITY
IMPROVED REACTIVITY
GLU351 MUTANT IMPROVED REACTIVITY
PLASMINOGEN ACTIVATOR INHIBITOR 1 IMPROVED REACTIVITY
INACTIVATED PAI-1
INCREASED AMOUNT
INCREASED RISK
CARDIOVASCULAR DISEASE INCREASED RISK
INDICATED MUTANT
INFECTION
INFLAMMATION
INHIBITED THROMBIN
INHIBITING THROMBIN
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
FIBROSARCOMA PAI-1 INHIBITORY ACTIVITY
WTPAI-1 INHIBITORY ACTIVITY
WTPAI-1 INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
INHIBITORY ACTIVITY
PLASMINOGEN ACTIVATOR INHIBITOR 1 INHIBITORY ACTIVITY
PLASMINOGEN ACTIVATOR INHIBITOR 1 INHIBITORY ACTIVITY
PLASMINOGEN ACTIVATOR INHIBITOR 1 INHIBITORY ACTIVITY
WTPAI-1 INHIBITORY ACTIVITY
WT-PAI-1 INHIBITORY ACTIVITY
WTPAI INHIBITORY ACTIVITY
INHIBITORY ACTIVITY(CONVERT TO LATENCY)
INHIBITORY CONFORMATION
INHIBITORY CONFORMATION
PLASMINOGEN ACTIVATOR INHIBITOR 1 INHIBITORY CONFORMATION
PLASMINOGEN ACTIVATOR INHIBITOR 1 INHIBITORY CONFORMATION
INSECT HIGH-5 CELL
INTERACTION
INTERACTION
KDA
KDA
KDA GLYCOPROTEIN
KINETIC ANALYSIS FIBROSARCOMA PAI-1
LABILE
LYSINE
MM S-2444
MM TRIS-HCL
MM SODIUM ACETATE
MM SODIUM ACETATE
MM SODIUM ACETATE
MM SODIUM ACETATE
MM Β-MERCAPTOETHANOL
MEASURING ASSAY BUFFER
MICROTITER PLATE
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN INCUBATION
ML/H
MODERATE REACTIVITY
MOLAR
MOLAR EXCESS
MOLAR EXCESS
THROMBIN MOLAR EXCESS
VITRONECTIN MOLAR EXCESS
MOLECULAR WEIGHT
WTPAI-1 MOLECULAR WEIGHT
MONOCLONAL ANTIBODY
MUTAGENESIS STUDY
MUTANT
MUTANT INHIBITOR
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
MUTANT
UPA MUTANT
INHIBITED THROMBIN MUTANT
NM
NM
NEOVASCULARIZATION
NEUTRALIZATION
NITROCELLULOSE PAPER
NM
NM
NM
NON
NON
CHARGED ANALOG ASPARAGINE NON
NON-COGNATE PROTEAS
NON-COVALENT INTERACTION
OPTICAL DENSITY
OPTIMAL FUNCTIONAL STABILITY
PLASMINOGEN ACTIVATOR INHIBITOR 1 OPTIMAL FUNCTIONAL STABILITY
OPTIMAL INTERACTION
OPTIMAL INTERACTION
ORDER INHIBITION CONSTANT
OTHER SERPIN
OTHER SERPIN
OTHER SERPIN
PH
PH
PH
PH
PH
PH
PPAI-1-AI
PRSET
PVL1393-PAI-1
PEPTIDE LOOP
PHOSPHATE-BUFFERED SALINE
PHYSIOLOGICAL INHIBITOR
TISSUE-TYPE PLASMINOGEN ACTIVATOR PHYSIOLOGICAL INHIBITOR
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN
PLASMIN ACTIVITY
PLASMIN INHIBITION
PLASMINOGEN ACTIVATOR INHIBITOR TYPE
PLASMINOGEN ACTIVATOR
POLYACRYLAMIDE GEL ELECTROPHORESI
POSITION GLU351
PRODUCING WTPAI-1
PRODUCTIVE ELECTROSTATIC INTERACTION
PROJECT
PROLINE
PROLINE
PROTEAS
PROTEIN
PURIFICATION
PURIFICATION
PURIFICATION
WTPAI-1 PURIFICATION
RATE CONSTANT
RATE CONSTANT
RATE CONSTANT
RATE CONSTANT
TPA RATE CONSTANT
WTPAI-1 TPA RATE CONSTANT
REACTIVATION
REACTIVE CENTER LOOP
REACTIVE CENTER LOOP
REACTIVE SITE
PLASMINOGEN ACTIVATOR INHIBITOR 1 REACTIVE SITE
REFOLDED
REFOLDING
REFOLDING
REPULSIVE INTERACTION
REPULSIVE INTERACTION
RESIDUAL PAI-1
INHIBITORY ACTIVITY RESIDUAL PAI-1
RESULTING MUTATION
RESULTS SHOW
ROOM TEMPERATURE
SECOND-ORDER RATE CONSTANT
SECOND-ORDER RATE CONSTANT
SEGMENT ASP355-ARG356-PRO357
PAI-1 YIELD GDN-HCL ACTIVATABLE INHIBITOR SEGMENT ASP355-ARG356-PRO357
SEQUENCED
SEQUENCING
SEQUENCING
SERINE PROTEASE INHIBITOR
SERINE PROTEASE SPECIFICITY
SERINE PROTEASES DOMAIN
SERINE PROTEASES SHOW
SERINE PROTEINASE INHIBITOR
SERPIN
SERPIN
SERPIN
SERPIN BODY-PROTEASE BODY INTERACTIONS PLAY
SERPIN
SERPIN
SILVER
SILVER
SILVER
SINGLE MUTATION
SINGLE SITE MUTATION
SINGLE SITE MUTATION
SINGLE-CHAIN TPA
SINGLE-CHAIN TPA
SINGLE-STEP ASSAY
SODIUM CHLORIDE
SODIUM DODECYLSULFATE
SOLE DETERMINANT
TARGET PROTEASE SPECIFICITY SOLE DETERMINANT
SPECIFICITY DETERMINANT
UPA SPECIFICITY DETERMINANT
SPONTANEOUS INACTIVATION
STANDARD PROCEDURE
STERIC HINDRANCE
STRUCTURAL SIMILARITY
SUBSTRATE S-2444
SUBSTRATE S-2444
SUPERNATENT
T-PA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TPA
TAKE PLACE
TARGET PROTEASE SPECIFICITY
TARGET PROTEAS
TARGET PROTEAS
TARGET PROTEAS
PLASMINOGEN ACTIVATOR INHIBITOR 1 TARGET PROTEAS
TARGET SPECIFICITY
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN
THROMBIN INHIBITION
THROMBIN INHIBITION
THROMBIN INHIBITION
THROMBIN PLAY
TIME POINT
TISSUE-TYPE PLASMINOGEN ACTIVATOR
TISSUE-TYPE PLASMINOGEN ACTIVATOR
TITRATION
ALIQUOT TITRATION
TRANSGENIC ANIMAL
TUMOR INVASION
TWO-CHAIN TPA
TWO-CHAIN TPA
UM TRIS-HCL
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA
UPA COMPLEX FORMATION
FIBROSARCOMA PAI-1 UPA COMPLEX FORMATION
UG
FIBROSARCOMA PAI-1 UG
UG/ML BSA
UROKINASE PLASMINOGEN ACTIVATOR
UROKINASE-TYPE PLASMINOGEN ACTIVATOR
VARIABLE REGION
VARIABLE REGION
VARIABLE REGION
VARIABLE REGION
TPA VARIABLE REGION
THROMBIN VARIABLE REGION
VARIABLE REGION
VASCULAR THROMBOSIS
VITRONECTIN
VITRONECTIN
VITRONECTIN
VITRONECTIN
VITRONECTIN
VITRONECTIN
VITRONECTIN
VITRONECTIN
VITRONECTIN
VITRONECTIN
VITRONECTIN
WT-PAI-1
WTPAI
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
WTPAI-1
ΜG/ML
ΜG/ML
ΜG/ML
ΜL
ΜL
PLASMINOGEN ACTIVATOR INHIBITOR-1
PAI-1
TYPE PLASMINOGEN         ACTIVATOR
TPA
UPA
STRAND 4A
S4A
HRP
ENHANCED           CHEMILUMINESCENCE
ECL
GDN-HCL
segments
segments
DNA SYNTHESIZER
DNA
PLASMINOGEN
activator
COGNATE PROTEASE
proteases
FORMATION
CONTROL
DNA MANIPULATION
sequencer
READER
FIBROSARCOMA
FIBROSARCOMA
GENERAL DNA
DNA
GLU351
analyses
increases
NON-COGNATE
PROTEASE SUBSTITUTION
proteases
POSITION DISPLAY
PAI-1 YIELD GDN-HCL ACTIVATABLE
ACTIVATABLE
DNA
SHMUEL SHALTIEL
QIAGEN MINIPREP
minipreps
UPA
RESULTS
SINGLE
THROMBIN
assay buffer
BACULOVIRUS
BACULOVIRUS
BETTER THROMBIN
THROMBIN
bovine serum
serum albumin
ACTIVATION
ANALOG ASPARAGINE
chromogenic
chromogenic
FORMATION
FORMATION
concentration
ranges
FORMATION
conformational
conformational
transitions
conformational
transitions
anti-mouse
positions
serpin inhibitory activity
SERPIN
chemiluminescence
chemiluminescence
enzymatic
enzymatic
DETERMINANT
functions
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
FIBROSARCOMA
preparation
concentration
concentration
concentration
concentration
HALF LIFE
HALF LIFE
times
PEROXIDASE
PEROXIDASE
HUMAN FIBROSARCOMA
FIBROSARCOMA
inhibition
reactivity
reactivity
RISK
THROMBIN
THROMBIN
CONFORMATION
CONFORMATION
KDA
glycoprotein
KINETIC ANALYSIS
FIBROSARCOMA
assay buffer
MIN
INCUBATION
reactivity
EXCESS
EXCESS
weights
MUTAGENESIS
MUTANT
nitrocellulose
papers
NON-COGNATE
INTERACTION
FUNCTIONAL STABILITY
INTERACTION
INTERACTION
ORDER INHIBITION
orders
peptides
inhibitors
PLASMIN
PLASMIN
inhibition
PLASMINOGEN ACTIVATOR INHIBITOR
PLASMINOGEN ACTIVATOR
PLASMINOGEN
activator
PLASMINOGEN
polyacrylamide
positions
GLU351
REACTIVE
REACTIVE
REACTIVE
INTERACTIONS
INTERACTIONS
RESULTS
shows
segments
ASP355-ARG356-PRO357
SERINE PROTEASE
serine
protease inhibitors
proteases
SERINE PROTEASE
serine
proteases
serine
PROTEASES DOMAIN
serine
serine
proteinase inhibitors
SERPIN
BODY-PROTEASE BODY INTERACTIONS PLAY
BODY INTERACTIONS PLAY
SINGLE
mutations
SINGLE
site mutations
SINGLE
TPA
TPA
DODECYLSULFATE
DETERMINANT
DETERMINANT
inactivation
standards
HINDRANCE
similarities
PLACE
targets
proteases
targets
targets
targets
targets
THROMBIN
inhibition
THROMBIN
inhibition
THROMBIN
inhibition
THROMBIN
plays
times
PLASMINOGEN ACTIVATOR
PLASMINOGEN
PLASMINOGEN ACTIVATOR
PLASMINOGEN
transgenic
INVASION
TPA
TPA
UM
UPA
COMPLEX FORMATION
ug/ml
BSA
UROKINASE
PLASMINOGEN ACTIVATOR
PLASMINOGEN
PLASMINOGEN ACTIVATOR
PLASMINOGEN
variables
variables
variables
variables
variables
